Combined pulmonary fibrosis and emphysema syndrome: A radiologic perspective

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 75, Issue 4, 2011, Pages 220-234

  Oliva, Isabel B ^a   Cortopassi, F ^a   Rochester, C L ^a,b   Rubinowitz, A N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Chronic obstructive pulmonary disease; Combined pulmonary fibrosis and emphysema; Computed tomography; Idiopathic pulmonary fibrosis

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; COMPUTER ASSISTED TOMOGRAPHY; EMPHYSEMA; HUMAN; IDIOPATHIC DISEASE; IMAGE ANALYSIS; LUNG FIBROSIS; PULMONARY HYPERTENSION; RADIATION; RADIOGRAPHY; REVIEW; THORAX RADIOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; FIBROSING ALVEOLITIS; INTERMETHOD COMPARISON; LUNG EMPHYSEMA;

EID: 84857516459     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2011.210     Document Type: Review

References (103)

1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412. (Pubitemid 43180921)
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349 (9065): 1498-504. (Pubitemid 27216360)
3. King TE, Jr., Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171-81. (Pubitemid 33052246)
4. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990; 84: 365-9. (Pubitemid 20287410)
5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
6. Kim DS, Collard HR, King TE, Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006; 3: 285-92. (Pubitemid 43845404)
7. Visscher DW, Myers JL. Histologic spectrum of idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006; 3: 322-9. (Pubitemid 43845409)
8. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157 (4 Pt 1): 1301-15.
9. Keane MP, Strieter RM, Lynch JP, 3rd, Belperio JA. Inflammation and angiogenesis in fibrotic lung disease. Semin Respir Crit Care Med 2006; 27: 589-99. (Pubitemid 46048039)
10. Schwartz DA, Helmers RA, Galvin JR, Van Fossen DS, Frees KL, Dayton CS, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149 (2 Pt 1): 450-4. (Pubitemid 24068994)
11. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134: 136-51. (Pubitemid 32096342)
12. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidencebased Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 2010; 183: 788-824.
13. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-72. (Pubitemid 24318021)
14. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161 (2 Pt 1): 646-64.
15. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810-6. (Pubitemid 44511663)
16. Nadrous HF, Myers JL, Decker PA, Ryu JH. Idiopathic pulmonary fibrosis in patients younger than 50 years. Mayo Clin Proc 2005; 80: 37-40. (Pubitemid 40075989)
17. Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 1994; 150: 670-5. (Pubitemid 24291493)
18. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-5. (Pubitemid 44787169)
19. Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Muller N, Schwartz DA, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003; 124: 1215-23. (Pubitemid 37290029)
20. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE, Jr., et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005; 142 (12 Pt 1): 963-7.
21. Horowitz JC, Thannickal VJ. Idiopathic pulmonary fibrosis: new concepts in pathogenesis and implications for drug therapy. Treat Respir Med 2006; 5: 325-42. (Pubitemid 44299832)
22. Weitzenblum E, Ehrhart M, Rasaholinjanahary J, Hirth C. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration 1983; 44: 118-27. (Pubitemid 13189310)
23. Newman JH. Pulmonary hypertension. Am J Respir Crit Care Med 2005; 172: 1072-7. (Pubitemid 43066641)
24. Panos RJ, Mortenson RL, Niccoli SA, King TE, Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990; 88: 396-404. (Pubitemid 20147276)
25. Murray CJ, Lopez AD. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science 1996; 274 (5288): 740-3. (Pubitemid 26398244)
26. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
27. Deaths from chronic obstructive pulmonary disease - United States, 2000-2005. MMWR Morb Mortal Wkly Rep 2008; 57: 1229-32.
28. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002; 51: 1-16.
29. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003 22: 268-73. (Pubitemid 36986996)
30. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366 (9500): 1875-81. (Pubitemid 41690116)
31. Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-9.
32. Tzanakis N, Anagnostopoulou U, Filaditaki V, Christaki P, Siafakas N. Prevalence of COPD in Greece. Chest 2004; 125: 892-900. (Pubitemid 38367279)
33. de Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59: 120-5. (Pubitemid 38223482)
34. Talamo C, de Oca MM, Halbert R, et al. Diagnostic labeling of COPD in five Latin American cities. Chest 2007; 131: 60-7.
35. Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care 2006; 51: 1120-4.
36. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76. (Pubitemid 32378468)
37. Prescott E. Tobacco-related diseases: the role of gender. An epidemiologic study based on data from the Copenhagen Centre for Prospective Population Studies. Dan Med Bull 2000; 47: 115-31. (Pubitemid 30216807)
38. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-46. (Pubitemid 38807371)
39. Rennard SI. Inflammation and repair processes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160 (5 Pt 2): S12-6.
40. Peinado VI, Barbera JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159 (5 Pt 1): 1605-11. (Pubitemid 29227877)
41. Matsuba K, Wright JL, Wiggs BR, Pare PD, Hogg JC. The changes in airways structure associated with reduced forced expiratory volume in one second. Eur Respir J 1989; 2: 834-9. (Pubitemid 19267623)
42. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med 2006; 100: 1742-52. (Pubitemid 44283760)
43. Snider GL, Kleinerman J, Thurlbeck WM, Bengali ZH. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 1985; 132: 182-5.
44. Stern EJ, Frank MS, Schmutz JF, Glenny RW, Schmidt RA, Godwin JD. Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. Am J Roentgenol 1994; 162: 555-60. (Pubitemid 24093553)
45. Fisher MR, Criner GJ, Fishman AP, et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J 2007; 30: 914-21. (Pubitemid 351194795)
46. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002; 166: 314-22. (Pubitemid 34864419)
47. Hoyle GW, Li J, Finkelstein JB, et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol 1999; 154: 1763-75. (Pubitemid 29262858)
48. Lucattelli M, Bartalesi B, Cavarra E, et al. Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Respir Res 2005; 6: 83.
49. Lundblad LK, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 2005; 171: 1363-70. (Pubitemid 40800508)
50. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-93. (Pubitemid 41448654)
51. Kosacka M, Brzecka A, Jankowska R, Lewczuk J, Mroczek E, Werynska B. Combined pulmonary fibrosis and emphysema - case report and literature review. Pneumonol Alergol Pol 2009; 77: 205-10.
52. Cottin V, Brillet PY, Nunes H, Cordier JF. Combined pulmonary fibrosis and emphysema. Presse Med 2007; 36 (6 Pt 2): 936-44.
53. Schwartz DA, Merchant RK, Helmers RA, Gilbert SR, Dayton CS, Hunninghake GW. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 144 (3 Pt 1): 504-6.
54. Hiwatari N, Shimura S, Takishima T. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration 1993; 60: 354-8. (Pubitemid 23348646)
55. Parry RA, Glaze SA, Archer BR. The AAPM/RSNA physics tutorial for residents. Typical patient radiation doses in diagnostic radiology. Radiographics 1999; 19: 1289-302.
56. Reich SB, Weinshelbaum A, Yee J. Correlation of radiographic measurements and pulmonary function tests in chronic obstructive pulmonary disease. Am J Roentgenol 1985; 144: 695-9. (Pubitemid 15080949)
57. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136: 225-44.
58. Burki NK. Roentgenologic diagnosis of emphysema. Accurate or not? Chest 1989; 95: 1178-9. (Pubitemid 19160134)
59. Foster WL, Jr., Gimenez EI, Roubidoux MA, et al. The emphysemas: radiologic-pathologic correlations. Radiographics 1993; 13: 311-28.
60. Pratt PC. Role of conventional chest radiography in diagnosis and exclusion of emphysema. Am J Med 1987; 82: 998-1006.
61. Thurlbeck WM, Muller NL. Emphysema: definition, imaging, and quantification. Am J Roentgenol 1994; 163: 1017-25. (Pubitemid 24355686)
62. Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978; 298: 934-9. (Pubitemid 8325838)
63. Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801-9. (Pubitemid 8313452)
64. Hurwitz LM, Reiman RE, Yoshizumi TT, et al. Radiation dose from contemporary cardiothoracic multidetector CT protocols with an anthropomorphic female phantom: implications for cancer induction. Radiology 2007; 245: 742-50. (Pubitemid 350127344)
65. Henschke CI, Boffetta P, Gorlova O, Yip R, Delancey J, Foy M. Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer 2011; 71: 328-32.
66. Foster WL, Jr., Pratt PC, Roggli VL, Godwin JD, Halvorsen RA, Jr., Putman CE. Centrilobular emphysema: CTpathologic correlation. Radiology 1986; 159: 27-32.
67. Hruban RH, Meziane MA, Zerhouni EA, et al. High resolution computed tomography of inflation-fixed lungs. Pathologic-radiologic correlation of centrilobular emphysema. Am Rev Respir Dis 1987; 136: 935-40. (Pubitemid 18028619)
68. Webb WR, Stein MG, Finkbeiner WE, Im JG, Lynch D, Gamsu G. Normal and diseased isolated lungs: highresolution CT. Radiology 1988; 166 (1 Pt 1): 81-7. (Pubitemid 18027049)
69. Webb WR. Thin-section CT of the secondary pulmonary lobule: anatomy and the image - the 2004 Fleischner lecture. Radiology 2006; 239: 322-38.
70. Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol 1982; 33: 379-87. (Pubitemid 12081355)
71. Hersh CP, Washko GR, Jacobson FL, et al. Interobserver variability in the determination of upper lobepredominant emphysema. Chest 2007; 131: 424-31.
72. Boedeker KL, McNitt-Gray MF, Rogers SR, et al. Emphysema: effect of reconstruction algorithm on CT imaging measures. Radiology 2004; 232: 295-301. (Pubitemid 38787852)
73. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: 653-7.
74. Gevenois PA, Scillia P, de Maertelaer V, Michils A, De Vuyst P, Yernault JC. The effects of age, sex, lung size, and hyperinflation on CT lung densitometry. Am J Roentgenol 1996; 167: 1169-73. (Pubitemid 26376230)
75. Parr DG, Stoel BC, Stolk J, Nightingale PG, Stockley RA. Influence of calibration on densitometric studies of emphysema progression using computed tomography. Am J Respir Crit Care Med 2004; 170: 883-90. (Pubitemid 39346484)
76. Stoel BC, Bakker ME, Stolk J, et al. Comparison of the sensitivities of 5 different computed tomography scanners for the assessment of the progression of pulmonary emphysema: a phantom study. Invest Radiol 2004; 39: 1-7. (Pubitemid 38030170)
77. Yuan R, Mayo JR, Hogg JC, et al. The effects of radiation dose and CT manufacturer on measurements of lung densitometry. Chest 2007; 132: 617-23. (Pubitemid 47282397)
78. Kuwano K, Matsuba K, Ikeda T, et al. The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores. Am Rev Respir Dis 1990; 141: 169-78. (Pubitemid 20023401)
79. Bergin CJ, Muller NL, Miller RR. CT in the qualitative assessment of emphysema. J Thorac Imaging 1986; 1: 94-103.
80. Kinsella M, Muller NL, Abboud RT, Morrison NJ, Dy- Buncio A. Quantitation of emphysema by computed tomography using a "density mask" program and correlation with pulmonary function tests. Chest 1990; 97: 315-21. (Pubitemid 20050666)
81. Sakai F, Gamsu G, Im JG, Ray CS. Pulmonary function abnormalities in patients with CT-determined emphysema. J Comput Assist Tomogr 1987; 11: 963-8. (Pubitemid 17164222)
82. Nishimura K, Murata K, Yamagishi M, et al. Comparison of different computed tomography scanning methods for quantifying emphysema. J Thorac Imaging 1998; 13: 193-8. (Pubitemid 28339876)
83. Staples CA, Muller NL, Vedal S, Abboud R, Ostrow D, Miller RR. Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings. Radiology 1987; 162: 377-81. (Pubitemid 17015640)
84. Terriff BA, Kwan SY, Chan-Yeung MM, Muller NL. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at followup in 26 patients. Radiology 1992; 184: 445-9.
85. Lynch DA, Godwin JD, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172: 488-93. (Pubitemid 41117395)
86. MacDonald SL, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221: 600-5. (Pubitemid 33101748)
87. Souza CA, Muller NL, Flint J, Wright JL, Churg A. Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings. Am J Roentgenol 2005; 185: 1531-9.
88. Johkoh T, Muller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211: 555-60. (Pubitemid 29206830)
89. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164: 193-6. (Pubitemid 34001280)
90. Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. Chest 1999; 116: 1168-74. (Pubitemid 29535965)
91. Mathieson JR, Mayo JR, Staples CA, Muller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171: 111-6. (Pubitemid 19093054)
92. Grenier P, Valeyre D, Cluzel P, Brauner MW, Lenoir S, Chastang C. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology 1991; 179: 123-32.
93. Lee KS, Primack SL, Staples CA, Mayo JR, Aldrich JE, Muller NL. Chronic infiltrative lung disease: comparison of diagnostic accuracies of radiography and low- and conventional- dose thin-section CT. Radiology 1994; 191: 669-73. (Pubitemid 24177883)
94. Battista G, Zompatori M, Fasano L, Pacilli A, Basile B. Progressive worsening of idiopathic pulmonary fibrosis. High resolution computed tomography (HRCT) study with functional correlations. Radiol Med 2003; 105: 2-11. (Pubitemid 36559771)
95. Flaherty KR, Mumford JA, Murray S, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 543-8. (Pubitemid 37088596)
96. Grosse C, Grosse A. CT findings in diseases associated with pulmonary hypertension: a current review. Radiographics 30: 1753-77.
97. Patel S, Kazerooni EA. Helical CT for the evaluation of acute pulmonary embolism. AJR Am J Roentgenol 2005; 185: 135-49.
98. Mamlouk MD, vanSonnenberg E, Gosalia R, et al. Pulmonary embolism at CT angiography: implications for appropriateness, cost, and radiation exposure in 2003 patients. Radiology 256: 625-32.
99. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354 (9173): 99-105. (Pubitemid 29313143)
100. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355: 1763-71. (Pubitemid 44631359)
101. Foy M, Yip R, Chen X, Kimmel M, Gorlova OY, Henschke CI. Modeling the mortality reduction due to computed tomography screening for lung cancer. Cancer 2011; 117: 2703-8.
102. http: //www.cancer.gov/newscenter/pressreleases/NLSTresultsRelease.
103. Brix G, Nagel HD, Stamm G, et al. Radiation exposure in multi-slice versus single-slice spiral CT: results of a nationwide survey. Eur Radiol 2003; 13: 1979-91. (Pubitemid 36949729)